Kenji Hiromatsu Selected Research

Kenji Hiromatsu Research Topics

Disease

6	Infections 07/2022 - 08/2003
5	Tuberculosis (Tuberculoses) 06/2011 - 07/2002
2	Communicable Diseases (Infectious Diseases) 07/2022 - 12/2019
2	Persistent Infection 07/2022 - 08/2004
2	COVID-19 05/2022 - 01/2022
2	Inflammation (Inflammations) 02/2021 - 07/2004
2	Hypersensitivity (Allergy) 06/2011 - 05/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2003 - 06/2002
1	Bacteremia 04/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Respiratory Syncytial Virus Infections 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Chorioamnionitis 02/2021
1	Chlamydophila Infections 01/2020
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 12/2018
1	Human Influenza (Influenza) 01/2017
1	Pseudomonas Infections 06/2015
1	Pancreatic Fistula (Pancreatic Fistulas) 06/2015
1	Infection with Mycobacterium marinum 06/2013
1	Neoplasms (Cancer) 08/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2012
1	Latent Tuberculosis 06/2011
1	Latent Infection 06/2011
1	Septic Shock (Toxic Shock Syndrome) 05/2010
1	Strongyloidiasis 01/2008
1	Hemorrhage 01/2008
1	Ileus 01/2008
1	Toxocariasis 01/2007
1	Visceral Larva Migrans 01/2006
1	Nematode Infections 08/2004
1	Colitis 07/2004
1	Eosinophilia 05/2004
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2002
4	LipidsIBA 06/2011 - 07/2002
3	AntigensIBA 05/2011 - 01/2003
2	DipeptidesIBA 07/2022 - 12/2019
2	VaccinesIBA 08/2012 - 08/2003
2	GlycolipidsIBA 05/2011 - 07/2002
1	Therapeutic UsesIBA 07/2022
1	Boron CompoundsIBA 07/2022
1	Bortezomib (Velcade)FDA Link 07/2022
1	COVID-19 VaccinesIBA 05/2022
1	BNT162 VaccineIBA 05/2022
1	beta-LactamsIBA 04/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	Ribosomal DNA (rDNA)IBA 02/2021
1	MicroRNAs (MicroRNA)IBA 02/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	MitoTEMPOIBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	15- methyl- 8- aza- 16- oxagona- 1,3,5(10),13- tetraen- 17- one (MAOTO)IBA 01/2017
1	TrypsinogenIBA 06/2015
1	CathelicidinsIBA 06/2013
1	Calcitriol (Calcijex)FDA LinkGeneric 06/2013
1	Vitamin D FDA LinkGeneric 06/2013
1	DNA (Deoxyribonucleic Acid)IBA 08/2012
1	DNA VaccinesIBA 08/2012
1	Aquaporins (Water Channels)IBA 08/2012
1	UbiquitinIBA 08/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2012
1	glycerol monomycolateIBA 06/2011
1	Tuberculin (PPD)IBA 05/2011
1	CytokinesIBA 05/2011
1	Interferon-gamma (Interferon, gamma)IBA 05/2010
1	SteroidsIBA 01/2008
1	Ivermectin (Mectizan)FDA Link 01/2008
1	Immunoglobulin G (IgG)IBA 01/2006
1	Eosinophil PeroxidaseIBA 08/2004
1	Interleukin-4 (Interleukin 4)IBA 08/2004
1	Messenger RNA (mRNA)IBA 08/2004
1	Interleukin-5 (Interleukin 5)IBA 08/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004
1	Interleukin-15 (Interleukin 15)IBA 07/2004
1	Sulfonic AcidsIBA 07/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2004
1	sym-trinitrobenzeneIBA 07/2004
1	Immunoglobulin E (IgE)IBA 05/2004
1	Liposomes (Liposome)IBA 08/2003
1	AerosolsIBA 08/2003
1	CD40 Ligand (CD40L)IBA 02/2003
1	CD1 AntigensIBA 01/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 02/2003
1	Pancreaticoduodenectomy 06/2015
1	Enteral Nutrition (Feeding, Tube) 05/2010
1	Total Parenteral Nutrition 05/2010
1	Enema (Enemas) 01/2008
1	Aftercare (After-Treatment) 01/2008
1	Colonic Pouches (S Pouch) 01/2007
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2004